X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (577) 577
Paper (285) 285
Publication (204) 204
Report (153) 153
Book / eBook (7) 7
Data Set (3) 3
Book Review (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cern lhc coll (397) 397
experimental results (385) 385
p p: scattering (321) 321
experiment (314) 314
cms (300) 300
p p: colliding beams (294) 294
particle physics (277) 277
physics (277) 277
high energy physics - experiment (272) 272
physics - high energy physics - experiment (252) 252
high energy physics (223) 223
13000 gev-cms (220) 220
physics of elementary particles and fields (192) 192
phenomenology (146) 146
scattering [p p] (125) 125
background (120) 120
hep (120) 120
physical sciences (119) 119
natural sciences (117) 117
naturvetenskap (117) 117
fysik (116) 116
colliding beams [p p] (115) 115
physics, particles & fields (112) 112
8000 gev-cms (103) 103
ex (101) 101
nuclear experiment (91) 91
transverse momentum: missing-energy (79) 79
supersymmetry (77) 77
hadron-hadron scattering (76) 76
channel cross section: upper limit (63) 63
humans (63) 63
index medicus (61) 61
final state:jet lepton (57) 57
[ phys.hexp ] physics [physics]/high energy physics - experiment [hep-ex] (54) 54
bottom: particle identification (54) 54
transverse momentum (54) 54
cern lab (52) 52
collisions (52) 52
z0: leptonic decay (51) 51
transverse momentum dependence (50) 50
data analysis method (49) 49
female (49) 49
jet: bottom (49) 49
astronomy & astrophysics (48) 48
elementary particles, quantum field theory (48) 48
quantum field theories, string theory (48) 48
male (47) 47
mass dependence (46) 46
kinematics (43) 43
top: pair production (43) 43
detectors (42) 42
muon: pair production (42) 42
squark: pair production (41) 41
middle aged (40) 40
物理学 (40) 40
channel cross section: measured (39) 39
astrophysics (38) 38
large hadron collider (38) 38
electroweak interaction (37) 37
final state:jet dilepton (37) 37
aged (36) 36
astronomy, astrophysics and cosmology (36) 36
lead (36) 36
w: leptonic decay (36) 36
rapidity dependence (35) 35
differential cross section: measured (33) 33
particle physics - experiment (33) 33
mass spectrum: (32) 32
mass: lower limit (32) 32
[phys.hexp]physics [physics]/high energy physics - experiment [hep-ex] (31) 31
measurement science and instrumentation (31) 31
new physics: search for (31) 31
nuclear energy (31) 31
nuclear physics, heavy ions, hadrons (31) 31
physics, nuclear (31) 31
subatomic physics (31) 31
subatomär fysik (31) 31
bottom: pair production (30) 30
gluino: pair production (30) 30
higgs particle: hadroproduction (30) 30
high energy astrophysical phenomena (30) 30
structure (30) 30
quantum chromodynamics: perturbation theory (29) 29
adult (28) 28
final state:jet (28) 28
instrumentation and detectors (28) 28
jet: transverse momentum (28) 28
parton distributions (28) 28
channel cross section: branching ratio: upper limit (27) 27
rapidity (27) 27
z0: associated production (27) 27
decay (26) 26
gluino: mass: lower limit (26) 26
gravitation (26) 26
sensitivity (26) 26
analysis (25) 25
jet lepton (25) 25
luminosity (25) 25
missing-energy [transverse momentum] (25) 25
nuclear physics (25) 25
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 6, pp. 521 - 529
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 12, pp. 1143 - 1150
Summary Background Sunitinib is a tyrosine kinase inhibitor with proven efficacy in renal-cell carcinoma, but some patients do not respond or need dose... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | VARIABILITY | INTERFERON-ALPHA | EFFICACY | ANGIOGENESIS | BIOMARKER | ONCOLOGY | GENOTYPE | VEGF | EXPRESSION | EXPOSURE | Predictive Value of Tests | Kidney Neoplasms - genetics | Prospective Studies | Humans | Middle Aged | Carcinoma, Renal Cell - genetics | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Patient Selection | Sunitinib | Cytochrome P-450 CYP3A - genetics | Time Factors | Antineoplastic Agents - adverse effects | Pyrroles - adverse effects | Female | Antineoplastic Agents - pharmacokinetics | Carcinoma, Renal Cell - drug therapy | Pyrroles - therapeutic use | Precision Medicine | Protein Kinase Inhibitors - pharmacokinetics | Genetic Predisposition to Disease | Risk Assessment | Carcinoma, Renal Cell - pathology | Gene Frequency | Risk Factors | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Spain | Disease-Free Survival | Homozygote | Phenotype | Indoles - adverse effects | Protein Kinase Inhibitors - therapeutic use | Heterozygote | Indoles - therapeutic use | Kidney Neoplasms - pathology | Aged | Polymorphism, Single Nucleotide | Kidney Neoplasms - drug therapy | Vascular Endothelial Growth Factor Receptor-3 - genetics | Genetic markers | Carcinoma | Toxicity | Oncology | Single-nucleotide polymorphism | Gene polymorphism | Protein-tyrosine kinase | Survival | Interleukin 8 | Vascular endothelial growth factor receptors | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 822 - 835
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 3, pp. 286 - 296
Journal Article
by Klionsky, Daniel J and Abdelmohsen, Kotb and Abe, Akihisa and Abedin, Md Joynal and Abeliovich, Hagai and Acevedo Arozena, Abraham and Adachi, Hiroaki and Adams, Christopher M and Adams, Peter D and Adeli, Khosrow and Adhihetty, Peter J and Adler, Sharon G and Agam, Galila and Agarwal, Rajesh and Aghi, Manish K and Agnello, Maria and Agostinis, Patrizia and Aguilar, Patricia V and Aguirre-Ghiso, Julio and Airoldi, Edoardo M and Ait-Si-Ali, Slimane and Akematsu, Takahiko and Akporiaye, Emmanuel T and Al-Rubeai, Mohamed and Albaiceta, Guillermo M and Albanese, Chris and Albani, Diego and Albert, Matthew L and Aldudo, Jesus and Algül, Hana and Alirezaei, Mehrdad and Alloza, Iraide and Almasan, Alexandru and Almonte-Beceril, Maylin and Alnemri, Emad S and Alonso, Covadonga and Altan-Bonnet, Nihal and Altieri, Dario C and Alvarez, Silvia and Alvarez-Erviti, Lydia and Alves, Sandro and Amadoro, Giuseppina and Amano, Atsuo and Amantini, Consuelo and Ambrosio, Santiago and Amelio, Ivano and Amer, Amal O and Amessou, Mohamed and Amon, Angelika and An, Zhenyi and Anania, Frank A and Andersen, Stig U and Andley, Usha P and Andreadi, Catherine K and Andrieu-Abadie, Nathalie and Anel, Alberto and Ann, David K and Anoopkumar-Dukie, Shailendra and Antonioli, Manuela and Aoki, Hiroshi and Apostolova, Nadezda and Aquila, Saveria and Aquilano, Katia and Araki, Koichi and Arama, Eli and Aranda, Agustin and Araya, Jun and Arcaro, Alexandre and Arias, Esperanza and Arimoto, Hirokazu and Ariosa, Aileen R and Armstrong, Jane L and Arnould, Thierry and Arsov, Ivica and Asanuma, Katsuhiko and Askanas, Valerie and Asselin, Eric and Atarashi, Ryuichiro and Atherton, Sally S and Atkin, Julie D and Attardi, Laura D and Auberger, Patrick and Auburger, Georg and Aurelian, Laure and Autelli, Riccardo and Avagliano, Laura and Avantaggiati, Maria Laura and Avrahami, Limor and Awale, Suresh and Azad, Neelam and Bachetti, Tiziana and Backer, Jonathan M and Bae, Dong-Hun and Bae, Jae-sung and Bae, Ok-Nam and Bae, Soo Han and Baehrecke, Eric H and Baek, Seung-Hoon and Baghdiguian, Stephen and Bagniewska-Zadworna, Agnieszka and ... and Medicinska fakulteten and Region Östergötland and Linköpings universitet and Institutionen för klinisk och experimentell medicin and Diagnostikcentrum and Klinisk patologi och klinisk genetik and Institutionen för medicin och hälsa and Avdelningen för läkemedelsforskning and Avdelningen för cellbiologi
Autophagy, ISSN 1554-8627, 01/2016, Volume 12, Issue 1, pp. 1 - 222
Journal Article